Latest Blog Posts Tagged "Therapies in development"
July 26, 2016
Last month scientists and physicians from around the world gathered at the International Congress of Parkinson's Disease and Movement Disorders to discuss emerging trends in care and research.
December 28, 2015
In this blog, we highlight research progress in 2015 and look forward to accomplishments in 2016.
December 14, 2015
Mark Frasier, PhD, Senior Vice President of Research Programs at MJFF, discusses Parkinson's disease research highlights from 2015.
November 24, 2015
Glutathione, a widely-available supplement, is being tested in clinical trials to determine if it helps Parkinson's symptoms. Read about what glutathione does and the ongoing research.
July 29, 2015
Drugs in development that go after the processes, rather than the proteins, involved in Alzheimer's onset may have potential to treat Parkinson's disease, as well.
June 26, 2015
MJFF staff share news from the 19th International Congress of Parkinson's Disease and Movement Disorders last week in San Diego.
June 25, 2015
Todd Sherer, PhD, shares updates on MJFF progress in 2015.
March 16, 2015
Our latest podcast covers how researchers are investigating ways to expand the current capabilities of deep brain stimulation.
April 29, 2014
Results from the first study on Parkinson's disease vaccine drug candidates are expected later this year.
Podcast: Drug That May Slow Parkinson's Progression Granted $23 Million from NIH for Phase III Testing
March 31, 2014
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.